Recursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia

Recursion today announced a grant from the AT-Children’s Project to advance it’s innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood genetic disease. [PR.com]
PR.com Press Releases: Medical & Health: Pharmaceuticals News

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us